AZACITIDINE FOR INJECTION

Google image searchProduct monograph

Active ingredient

azacitidine, 100 MG/VIAL

DIN: 02507668

Dosage form(s): POWDER FOR SUSPENSION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: HIKMA CANADA LIMITED

Date: 24-FEB-2022

ATC:

Reference brand drug: Vidaza

Pharmaceutical standard: MFR

Search on Google